Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Elcelyx Therapeutics Raises $4M to Treat Obesity and Diabetes 08/13/12 San Diego
Genentech Gets FDA OK of Lucentis for Diabetic Eye Disease 08/10/12 San Francisco
Novo Nordisk Weaves Itself Into Seattle Biotech, With Diabetes R&D 07/06/12 Seattle
San Diego Life Sciences Roundup: Amylin Buyout, PDUFA, & More 07/05/12 San Diego
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
SD Life Sciences Roundup: Arena, PatientSafe, MEI Pharma, & More 06/28/12 San Diego
SD Life Sciences Roundup: Ambrx Gets Big Partner, GenMark, & More 06/21/12 National
Seventh Sense, Polaris, & More Boston Life Sciences Newsmakers 06/15/12 Boston
SD at Center of Shire’s Plan for Regenerative Medicine Business 06/14/12 San Diego
Rhythm Drums Up $25M to Advance Diabetes and Obesity Drugs 06/13/12 Boston
N-Gene Digs Up Funds to Boost “Heat Shock” Drug in Diabetes and MD 04/25/12 New York
Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid 03/28/12 San Diego
‘Breakthrough’ in Quantified Health Sets Stage for Innovation Summit 03/22/12 San Diego
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug 01/27/12 National
Novo Nordisk Adds Diabetes Research to Seattle Immunology Team 01/23/12 Seattle
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More 01/12/12 San Diego
Cebix to Raise $20 Million for Pivotal Trial of Diabetes Supplement 01/10/12 San Diego
Cure for Diabetes 12/28/11 San Francisco
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug 11/29/11 Boston
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) 11/22/11 National
FDA Clears Portable Insulin Pump from San Diego’s Tandem Diabetes 11/16/11 San Diego
Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships 11/15/11 New York
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes 11/10/11 New York
Rhythm Adds Former Merck VP as CEO 11/09/11 Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact 11/08/11 San Diego
Page 3 of 12 « previous page · next page »